HRT Financial’s Elevation Oncology ELEV Stock Holding History

HRT Financial’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-38,243	Closed	-$14K	–	3039
2025 Q2	$14K	Buy	+38,243	New	+$12.8K	﹤0.01%	2426
2024 Q2	–	Sell	-133,268	Closed	-$683K	–	2434
2024 Q1	$683K	Buy	+133,268	New	+$432K	﹤0.01%	1084

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HRT Financial's ELEV Position: Q3 2025 in Review

HRT Financial sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 38,243 shares — an estimated $14K sold.

HRT Financial first reported a position in ELEV in Q1 2024 and held it in 2 quarters. The position peaked at $683K in Q1 2024. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

HRT Financial reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
HRT Financial sold 38,243 Elevation Oncology shares in Q3 2025, an estimated $14K.
HRT Financial first reported a position in Elevation Oncology in Q1 2024 and held it in 2 quarters.
HRT Financial's Elevation Oncology position peaked at $683K in Q1 2024.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.